正在加载视频...

视频加载失败

加载此视频时出现问题。这可能是由于临时网络问题，或视频可能不可用。

Patients and scientists have been completely disconnected from one another. DeSci aims to bridge this gap. Paul Kohlhaas bio/acc sharing insights on a new approach to drug development

Bio Protocol

116,142 subscribers

11,746 次观看 • 1 年前 •via X (Twitter)

Anya Rossi• Live Now

Private livecam show

0 条评论

暂无评论

原始帖子的评论将显示在这里

相关视频

How do we 1000x DeSci in 2025? Starting in Q1, the BIO Launchpad is evolving into an autonomous, community-owned protocol that makes BioDAO creation open, accessible and fun. $BIO holders curate and get whitelisted in new BioDAOs. Paul Kohlhaas bio/acc joined BlockBeats｜We're hiring! to preview the mechanics.

How do we 1000x DeSci in 2025? Starting in Q1, the BIO Launchpad is evolving into an autonomous, community-owned protocol that makes BioDAO creation open, accessible and fun. $BIO holders curate and get whitelisted in new BioDAOs. Paul Kohlhaas bio/acc joined BlockBeats｜We're hiring! to preview the mechanics.

Bio Protocol

82,393 次观看 • 1 年前

How does DeSci bring science to consumers faster? At DeSci Abu Dhabi, Paul Kohlhaas bio/acc announced that Bio is building a ’Shopify’ for science-backed health products. DeSci’s edge: > Community-driven feedback & development bring science to market faster > Token incentives scale organic demand > BioAgents drive personalization & consumer discovery Initial featured products will include DermaDAO skin care, HairDAO 💈 hair-loss treatments, Cerebrum DAO 🧠 brain health supplement & more. More soon! Watch the full DeSci Abu Dhabi livestream below ↓

How does DeSci bring science to consumers faster? At DeSci Abu Dhabi, Paul Kohlhaas bio/acc announced that Bio is building a ’Shopify’ for science-backed health products. DeSci’s edge: > Community-driven feedback & development bring science to market faster > Token incentives scale organic demand > BioAgents drive personalization & consumer discovery Initial featured products will include DermaDAO skin care, HairDAO 💈 hair-loss treatments, Cerebrum DAO 🧠 brain health supplement & more. More soon! Watch the full DeSci Abu Dhabi livestream below ↓

Bio Protocol

11,314 次观看 • 8 个月前

DeSci isn’t about DISRUPTING science; it’s about ACCELERATING it. From funding biotech IP to real clinical trials, Bio Protocol is building for the long term. Paul Kohlhaas bio/acc explains why real-world assets matter more than hype cycles. Watch his full interview with Jorge | The Gaming Strategist below 👇

DeSci isn’t about DISRUPTING science; it’s about ACCELERATING it. From funding biotech IP to real clinical trials, Bio Protocol is building for the long term. Paul Kohlhaas bio/acc explains why real-world assets matter more than hype cycles. Watch his full interview with Jorge | The Gaming Strategist below 👇

DeSci News

34,166 次观看 • 7 个月前

Our new recommendations published today in The Lancet Oncology spotlight the need for assessing ovarian toxicity in #ClinicalTrials. This aims to bridge the information gap helping patients make informed treatment choices. ➡️ #OncTwitter

Our new recommendations published today in The Lancet Oncology spotlight the need for assessing ovarian toxicity in #ClinicalTrials. This aims to bridge the information gap helping patients make informed treatment choices. ➡️ #OncTwitter

ASCO

48,233 次观看 • 2 年前

IMPORTANT MESSAGE FROM DR AMBRISH MITHAL I have learnt from friends and patients that an advertisement for a drug Diofin for "curing" diabetes is being widely circulated, supposedly endorsed by me. The claim is accompanied with detailed descriptions about my research saying that I discovered and developed this drug. I wish to say that this is completely false. I do not know of this drug and I have not been involved in its development. I have never even heard of this drug prior to this episode. The post also refers to minute details of my life, education and qualifications to seem authentic. All these personal details are also false. I would like to reiterate that this advertisement is a complete fabrication. Please do not get misled. Meanwhile appropriate steps have been initiated to address this false advertising.

IMPORTANT MESSAGE FROM DR AMBRISH MITHAL I have learnt from friends and patients that an advertisement for a drug Diofin for "curing" diabetes is being widely circulated, supposedly endorsed by me. The claim is accompanied with detailed descriptions about my research saying that I discovered and developed this drug. I wish to say that this is completely false. I do not know of this drug and I have not been involved in its development. I have never even heard of this drug prior to this episode. The post also refers to minute details of my life, education and qualifications to seem authentic. All these personal details are also false. I would like to reiterate that this advertisement is a complete fabrication. Please do not get misled. Meanwhile appropriate steps have been initiated to address this false advertising.

Dr Ambrish Mithal

17,341 次观看 • 2 个月前

🚨NEW EPISODE🚨 What is DeSci? With Paul Kohlhaas bio/acc CEO & Co-founder Bio Protocol & Alex Mukhin Co-lead . In this episode below we discuss: - What exactly is DeSci? - How is set to increase human longevity - How does crypto solve medical research? - Medical investment incentives - What is VITA-FAST? - How is development enforced - What are the traditional medical investment dynamics? - Is DeSci a hype cycle? - What is Pump Science & $RIF? - DeSci's roadmap Full ep in this tweet or via links below: 📺Youtube: 🎙️Spotify: 🎙️Apple: -- Timestamps: (00:00) Introduction (02:28) What is DeSci? (03:35) Paul’s background (07:27) VitaDAO user experience (09:34) VitaDAO’s use case (12:17) How does crypto solve medical research? (16:44) VitaDAO demographic (19:50) Investment incentives (24:09) VITA-FAST (27:05) Development enforcement (32:14) Traditional medical investment dynamics (35:07) Is DeSci a hype cycle? (40:08) What is & $RIF? (45:22) DeSci roadmap (49:35) Outro --

🚨NEW EPISODE🚨 What is DeSci? With Paul Kohlhaas bio/acc CEO & Co-founder Bio Protocol & Alex Mukhin Co-lead . In this episode below we discuss: - What exactly is DeSci? - How is set to increase human longevity - How does crypto solve medical research? - Medical investment incentives - What is VITA-FAST? - How is development enforced - What are the traditional medical investment dynamics? - Is DeSci a hype cycle? - What is Pump Science & $RIF? - DeSci's roadmap Full ep in this tweet or via links below: 📺Youtube: 🎙️Spotify: 🎙️Apple: -- Timestamps: (00:00) Introduction (02:28) What is DeSci? (03:35) Paul’s background (07:27) VitaDAO user experience (09:34) VitaDAO’s use case (12:17) How does crypto solve medical research? (16:44) VitaDAO demographic (19:50) Investment incentives (24:09) VITA-FAST (27:05) Development enforcement (32:14) Traditional medical investment dynamics (35:07) Is DeSci a hype cycle? (40:08) What is & $RIF? (45:22) DeSci roadmap (49:35) Outro --

BLOCKCRUNCH

11,198 次观看 • 1 年前

This ARMY has documented all the instances there have been updates on the guys this year. 1960 times. ONE THOUSAND NINE HUNDRED AND SIXTY instances were recorded. Link to the document on the acc bio.

This ARMY has documented all the instances there have been updates on the guys this year. 1960 times. ONE THOUSAND NINE HUNDRED AND SIXTY instances were recorded. Link to the document on the acc bio.

JRJ ㉧㉣㉣

406,145 次观看 • 8 个月前

The bridge is Live: Real development takes time. Easier to have ChatGPT write a Whitepaper and ask every KOL to shill. From now on, we can finally follow up with a lot more Business Development!

The bridge is Live: Real development takes time. Easier to have ChatGPT write a Whitepaper and ask every KOL to shill. From now on, we can finally follow up with a lot more Business Development!

BRCport

259,180 次观看 • 2 年前

.Ochre Bio is on a mission to revolutionize liver disease treatment. Co-Founder + CEO Jack O'Meara talks with Judy Khan Shaw about their 'human first' approach and how machine learning technology sets them apart in drug development on #NYSEFloorTalk.

.Ochre Bio is on a mission to revolutionize liver disease treatment. Co-Founder + CEO Jack O'Meara talks with Judy Khan Shaw about their 'human first' approach and how machine learning technology sets them apart in drug development on #NYSEFloorTalk.

NYSE 🏛

19,813 次观看 • 2 年前

🗣️Our new Coach Development pathway! From the new E&D strategy, we are delighted to share our new pathway which focuses on development. Developing expertise through age & stage appropriate, individualised approach and a focus on expertise! #CoachDevelopment

🗣️Our new Coach Development pathway! From the new E&D strategy, we are delighted to share our new pathway which focuses on development. Developing expertise through age & stage appropriate, individualised approach and a focus on expertise! #CoachDevelopment

FAI Coach Development

13,980 次观看 • 1 年前

Sharing moments shouldn’t depend on the phone you have. Starting today with the Pixel 10 family, Quick Share now works with AirDrop, making secure file transfers between Android phones and iPhones more seamless. This builds on our commitment to cross-OS compatibility to bridge the gap between ecosystems. We built this feature with security top of mind from day one. Learn more ↓

Sharing moments shouldn’t depend on the phone you have. Starting today with the Pixel 10 family, Quick Share now works with AirDrop, making secure file transfers between Android phones and iPhones more seamless. This builds on our commitment to cross-OS compatibility to bridge the gap between ecosystems. We built this feature with security top of mind from day one. Learn more ↓

Android

8,670,426 次观看 • 9 个月前

All cancer patients deserve a timely diagnosis and access to the latest, most effective treatment #WorldCancerDay #Myeloma still has one of the longest times to diagnosis of any cancer. Help us to close the care gap by sharing this post and raising awareness 🧡

All cancer patients deserve a timely diagnosis and access to the latest, most effective treatment #WorldCancerDay #Myeloma still has one of the longest times to diagnosis of any cancer. Help us to close the care gap by sharing this post and raising awareness 🧡

Myeloma UK

34,448 次观看 • 2 年前

Colossal Biosciences, a biotech company that aims to resurrect lost creatures, said it has hatched live chicks in an artificial environment — a development that was met with mixed reviews from scientists and critics. Read more:

Colossal Biosciences, a biotech company that aims to resurrect lost creatures, said it has hatched live chicks in an artificial environment — a development that was met with mixed reviews from scientists and critics. Read more:

The Associated Press

186,552 次观看 • 3 个月前

Summary of Idumota Open Drug Market Operation (Week One) The ongoing enforcement aims to eliminate illicit drugs and curb the circulation of unregistered, expired, revalidated, and controlled medicines. So far, over 3,000 shops have been screened and placed on hold.

Summary of Idumota Open Drug Market Operation (Week One) The ongoing enforcement aims to eliminate illicit drugs and curb the circulation of unregistered, expired, revalidated, and controlled medicines. So far, over 3,000 shops have been screened and placed on hold.

NAFDAC NIGERIA

178,723 次观看 • 1 年前

CCCC Tanzania Branch hosted an engineering science open day at the Jangwani Bridge project, welcoming over 50 engineering professionals to explore bridge construction technologies. Visitors toured key work areas, learned about construction processes, and exchanged insights on quality control and safety management, strengthening knowledge sharing in Tanzania’s infrastructure development.

CCCC Tanzania Branch hosted an engineering science open day at the Jangwani Bridge project, welcoming over 50 engineering professionals to explore bridge construction technologies. Visitors toured key work areas, learned about construction processes, and exchanged insights on quality control and safety management, strengthening knowledge sharing in Tanzania’s infrastructure development.

CCCC Tanzania

12,549 次观看 • 1 个月前

.President Donald J. Trump on the Trump Administration's new initiative to make electronic patient health records more accessible: "This will allow patients to easily transmit information from one doctor to another, even if they're on different networks."

.President Donald J. Trump on the Trump Administration's new initiative to make electronic patient health records more accessible: "This will allow patients to easily transmit information from one doctor to another, even if they're on different networks."

Rapid Response 47

59,088 次观看 • 1 年前